Market Cap : 6.69 M | Enterprise Value : 6.56 M | P/E (TTM) : | P/B : |
---|
OTCPK:ICOTF has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
OTCPK:ICOTF has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
PEG is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, iCo Therapeutics's PE Ratio without NRI is 0.00. iCo Therapeutics's 5-Year EBITDA growth rate is 9.10%. Therefore, iCo Therapeutics's PEG for today is 0.00.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate.
Peter Lynch thinks a company with a P/E (NRI) ratio equal to its growth rate is fairly valued.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
* The bar in red indicates where iCo Therapeutics's PEG Ratio falls into.
PEG is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.
iCo Therapeutics's PEG for today is calculated as
PEG | = | PE Ratio without NRI | / | 5-Year EBITDA Growth Rate* |
= | / | 9.10 | ||
= | 0.00 |
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. If it's smaller than or equal to 0, then the PEG ratio is not calculated.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG. PEG is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
No Headline